XNAS: FENC
Fennec Pharma Inc Live Stock Price Today, Share Analysis and Chart
about
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The comp...
Read More
7.52
-0.11
(-1.44%)
86,018
XNAS Volume
XNAS 13 Mar, 2026 5:30 PM (EDT)
Board Meeting
The next board meeting for Fennec Pharma Inc is on 17 Mar 2026 for the purpose of Fennec Pharmaceuticals Inc Fourth Quarter Earnings Conference Call for 2025
See details
Not Eligible
Expensive Valuation
Technically Bearish
Fennec Pharma Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..